International Journal of Pharmaceutical Investigation · Archive
Volumes & Issues
Open a volume to see its issues, then pick an issue for its cover art and complete table of contents.
Keyboard: use Up/Down arrows to move between volumes, Home/End to jump to the first or last, and Enter to open or close a volume.
In this issue
Review Article
Review ArticlePublished: 1 Aug 2016
Kannissery Pramod, M. Abu Tahir, Naseem A. Charoo, Shahid H. Ansari, Javed Ali
pp. 129-138 · DOI: 10.4103/2230-973X.187350Vol. 6, Issue 3 (2016)The application of quality by design (QbD) in pharmaceutical product development is now a thrust area for the regulatory authorities and the pharmaceutical industry. International Conference on Harmonization and United S…
Original Research Article
Original Research ArticlePublished: 1 Aug 2016
Kenneth C. Ofokansi, Franklin C. Kenechukwu, Richard O. Ezugwu, Anthony A. Attama
pp. 139-147 · DOI: 10.4103/2230-973X.187344Vol. 6, Issue 3 (2016)Background: The purpose of this study was to develop ibuprofen (IB)-polyethylene glycol (PEG) 8000 solid dispersions (SDs) and investigate them for in vitro dissolution and in vivo anti-inflammatory activity. Materials a…
Original Research ArticlePublished: 1 Aug 2016
Nallaguntla Lavanya, Yallamalli Indira Muzib, Jithan Aukunuru, Umamahesh Balekari
pp. 148-157 · DOI: 10.4103/2230-973X.187351Vol. 6, Issue 3 (2016)Objective: The objective of the present work was to prepare and evaluate a novel oral formulation for systemic delivery of low molecular weight heparin (LMWH). The formulation consisted of Eudragit S 100-coated positivel…
Original Research ArticlePublished: 1 Aug 2016
Vaishali Thakkar, Vaishali Korat, Lalji Baldaniya, Mukesh Gohel, Tejal Gandhi, Nirav Patel
pp. 158-168 · DOI: 10.4103/2230-973X.187343Vol. 6, Issue 3 (2016)Introduction: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; c…
Original Research ArticlePublished: 1 Aug 2016
Govada Kishore Babu, Puttagunta Srinivasa Babu, Mukkanti Khagga
pp. 169-179 · DOI: 10.4103/2230-973X.187345Vol. 6, Issue 3 (2016)Introduction: Valsartan is a type II Biopharmaceutics Classification System (BCS) classified drug. The poor aqueous solubility restricts its use in developing sustained or controlled release systems for the treatment of …